Analysts postive on Nektar opportunity after Sanofi data

September 4, 2025 3:38 PM UTC Send to a Friend
Investing.com -- Nektar Therapeutics shares jumped as much as 25% on Thursday, marking the largest intraday gain since June, after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login